In contrast, we found that tumors without high-quality neoantigens and CD8+ T cells harbored a number of recurrently mutated genes (somatic mutations and CNVs; Fig. 5c, d), some of which are important cancer drivers. This evidence concerns the gene CD8A and cancer.